Taipei, Tuesday, September 26, 2017 12:09 (GMT+8)
partly cloudy
Taipei
35°C
PCB maker Apex to see capacity utilization rate drop to 80% in 4Q12 - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Thursday 11 October 2012]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$33.1 on the TSE on Monday, September 25, 2017.
    The company has reported consolidated revenues of NT$146 million for August 2017, representing a 18.4% drop on month and 19.3% increase on year.
    For the second quarter of 2017, the company totaled NT$420 million in consolidated revenues, down 1.2% sequentially and down 17.5% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    26-Sep 57   33.10 33.50 33.10 33.20+0.10+0.30%  
    25-Sep 424 179 14,046,184 33.45 33.45 33.00 33.10-0.35-1.05% 33.10 33.15
    22-Sep 379 157 12,719,599 34.10 34.10 33.45 33.45-0.60-1.76% 33.45 33.50
    21-Sep 127 86 4,329,536 33.80 34.15 33.75 34.05+0.35+1.04% 34.00 34.05
    20-Sep 197 121 6,643,200 33.60 33.95 33.60 33.70-0.15-0.44% 33.70 33.75
    19-Sep 266 152 9,063,092 34.20 34.30 33.80 33.85-0.35-1.02% 33.85 33.90
    18-Sep 87 67 2,975,835 34.20 34.30 34.15 34.20+0.00+0.00% 34.20 34.25
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Aug 2016 - Aug 2017 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Aug-17

    146

    (18.4%)

    19.3%

    1,169

    (7.4%)

    Jul-17

    179

    16.7%

    19.1%

    1,024

    (10.3%)

    Jun-17

    153

    17.6%

    (4.5%)

    845

    (14.8%)

    May-17

    130

    (4.6%)

    (21.7%)

    692

    (16.7%)

    Apr-17

    136

    (22.2%)

    (25.2%)

    561

    (15.5%)

    Mar-17

    175

    77.6%

    (6.2%)

    425

    (11.8%)

    Feb-17

    99

    (34.6%)

    (25.8%)

    250

    (15.4%)

    Jan-17

    151

    27.1%

    (6.9%)

    151

    (6.9%)

    Dec-16

    119

    (14%)

    (14%)

    1,786

    (3.4%)

    Nov-16

    138

    2.8%

    (16.2%)

    1,667

    (2.5%)

    Oct-16

    134

    2.7%

    (24%)

    1,529

    (1%)

    Sep-16

    131

    7.1%

    (17.1%)

    1,394

    1.9%

    Aug-16

    122

    (18.5%)

    (18.9%)

    1,263

    4.4%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, September 2017

    Apex: Consolidated revenues, 2Q16 - 2Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    2Q-17

    420

    (1.2%)

    (17.5%)

    845

    (14.8%)

    1Q-17

    425

    15.2%

    (11.8%)

    425

    (11.8%)

    4Q-16

    369

    (8.5%)

    (23.1%)

    1,763

    (4.6%)

    3Q-16

    403

    (20.8%)

    (14.3%)

    1,394

    1.9%

    2Q-16

    509

    5.6%

    20.4%

    991

    10.5%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, September 2017

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 2Q16 - 2Q17 (NT$k)

    Item

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    2Q-2016

    Current assets

    1,632,388

    1,647,085

    1,602,788

    1,783,928

    1,758,668

    Intangible assets

    314,386

    25,010

    25,854

    26,609

    27,768

    Non-current assets

    1,143,758

    880,663

    897,998

    1,075,070

    1,093,237

    Assets

    2,776,146

    2,527,748

    2,500,786

    2,858,998

    2,851,905

    Current liabilities

    818,230

    482,436

    414,574

    642,761

    637,716

    Non-current liabilities

    355,661

    354,649

    353,912

    355,451

    355,390

    Liabilities

    1,173,891

    837,085

    768,486

    998,212

    993,106

    Stockholders' equity

    1,602,255

    1,690,663

    1,732,300

    1,860,786

    1,858,799

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, September 2017

    Apex: Consolidated income statement, 2Q16 - 2Q17 (NT$k)

    Item

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    2Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    419,801

     

    424,990

     

     

     

     

     

    509,022

     

    Operating revenue

    419,801

    100%

    424,990

    100%

    368,972

    72.5%

    403,241

    79.2%

    509,022

    100%

    Gross profit (loss) from operations

    89,252

    21.3%

    75,548

    17.8%

    89,255

    17.5%

    91,021

    17.9%

    144,414

    28.4%

    Operating expenses

    47,662

    11.4%

    60,894

    14.3%

    56,217

    11%

    55,379

    10.9%

    65,686

    12.9%

    Operating income (loss)

    41,590

    9.9%

    14,654

    3.4%

    33,038

    6.5%

    35,642

    7%

    78,728

    15.5%

    Non-operating expenses and losses

    19,106

    4.6%

    -53,646

    -12.6%

    -144,637

    -28.4%

    -34,016

    -6.7%

    1,175

    0.2%

    Income from continuing operations before income tax

    60,696

    14.5%

    -38,992

    -9.2%

    -111,599

    -21.9%

    1,626

    0.3%

    79,903

    15.7%

    Net income (loss)

    57,277

    13.6%

    -38,992

    -9.2%

    -130,469

    -25.6%

    1,245

    0.2%

    64,908

    12.8%

    Diluted earnings per share (NT$)

    0

     

     

     

    0

     

     

     

    0.6

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, September 2017

  • Apex Biotechnology full profile
Realtime news
  • Smartphone sales in Taiwan remain sluggish in August

    Mobile + telecom | 20min ago

  • China January-August software revenues total CNY3.460 trillion

    IT + CE | 25min ago

  • China August mobile communication users grows to 1.382 billion

    Mobile + telecom | 29min ago

  • Wearable brands releasing new devices

    IT + CE | 35min ago

  • Samsung ready to mass produce MRAM chips using 28nm FD-SOI process

    Bits + chips | 37min ago

  • Digitimes Research: Apple outraces Google for on-device AI development

    Mobile + telecom | 50min ago

  • SMIC to build new plant in Ningbo

    Bits + chips | 1h 2min ago

  • Mikro Mesa, ITRI developing micro LED panels

    LED | 1h 10min ago

  • Sigurd to enter board of Winstek

    Bits + chips | 1h 39min ago

  • MEMS sensor demand for smartphones, automotive surging

    Before Going to Press | Sep 25, 22:23

  • Samsung certifies Synopsys design platform for 28nm FD-SOI process

    Before Going to Press | Sep 25, 22:23

Pause
 | 
View more

26-Sep-2017 09:45 (GMT+8)

 LastChange

TAIEX (TSE)10370.47+34.58+0.33% 

TSE electronic438.64+1.29+0.29% 

GTSM (OTC)139.83-0.13-0.09% 

OTC electronic206.4-0.81-0.39% 

Global notebook shipment forecast, 2017 and beyond
Global AP demand forecast, 2017-2020
Global notebook shipment forecast, 2017 and beyond
  • The 10nm competition

    TSMC and Samsung have been competing for clients for the 10nm node.

  • SEMICON Taiwan 2017

    Semiconductor equipment and material suppliers are showcasing their latest products and technologies at SEMICON Taiwan 2017 in Taipei September 13-15.

  • Memory price rally

    DRAM prices have been rising amid tight supply.

  • ASE-SPIL merger

    A proposed merger between Advanced Semiconductor Engineering (ASE) and Siliconware Precision Industries (SPIL) has yet to receive approval from the US...

  • China AMOLED panel capacity expansion forecast, 2016-2020

    This Digitimes Research Special Report examines the China AMOLED industry, focusing on the expansion capacity of the makers, the current implementation plans of major smartphone vendors in the market and the technological hurdles faced by the China makers.

  • Global AP demand forecast, 2017-2020

    Digitimes Research expects global AP shipments to surpass the 1.9 billion mark in 2017, with smartphones remaining the main application. Qualcomm will be leading the market in 2017, as other players continue playing catch up and scramble for funds to invest in more diverse applications.

  • Global notebook shipment forecast, 2017 and beyond

    This Digitimes Special Report examines key factors in the notebook industry, including products, vendors and ODMs, that will affect total shipments in 2017 and through 2021.